Lilly Finalizes Centessa Acquisition, Bolstering Sleep-Wake Disorder Pipeline
Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment
Positive
Importance
8
Price
$1,112.01
Mkt Cap
$1.043T
52W Low
$623.78
52W High
$1,182.73
52W Position
78% above low
Off High
6.0% below high
Rel. Volume
1.0× avg
Market data snapshot near publication time
LLY sits 78% above its 52-week low of $623.78.
Summary
Eli Lilly has completed its acquisition of Centessa Pharmaceuticals, a move aimed at advancing treatments for sleep-wake disorders. This follows the initial agreement announced on April 1st, 2026, regarding assets from Centessa. The completion allows Lilly to integrate Centessa's pipeline and intellectual property, strengthening its position in a key therapeutic area.
At the time of this announcement, LLY was trading at $1,112.01 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1T. The 52-week trading range was $623.78 to $1,182.73. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.
Price Chart
LLY - Latest Insights
LLY
Oct 02, 2026, 3:05 PM EDT
Price at Filing:
$1,147.30
Real-time Price:
$1,143.60
Change:
-$3.70 (-0.32%)
Market Cap:
$1.076T
LLY
Oct 01, 2026, 7:01 AM EDT
Price at Filing:
$1,158.84
Real-time Price:
$1,143.60
Change:
-$15.24 (-1%)
Market Cap:
$1.076T
LLY
Sep 30, 2026, 6:29 PM EDT
Price at Filing:
$1,162.58
Real-time Price:
$1,143.60
Change:
-$18.97 (-2%)
Market Cap:
$1.076T
LLY
Sep 30, 2026, 10:15 AM EDT
Price at Filing:
$1,188.91
Real-time Price:
$1,143.60
Change:
-$45.30 (-4%)
Market Cap:
$1.076T
LLY
Sep 29, 2026, 8:01 AM EDT
Price at Filing:
$1,186.46
Real-time Price:
$1,143.60
Change:
-$42.86 (-4%)
Market Cap:
$1.076T